We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
The big bucks is the Antibody Test. The collaboration with Oxford University had a key aim of producing a test is to find the Antibody produced by the Oxford vaccine. If the Oxford vaccine is a success it will blast the consortium into orbit. I think the Antigen test is a non starter in this country because of political malpractice but it will be lucrative elsewhere .
Good factual post MU345. Best of luck to all genuine investors.
As per the below which was updated on the 24th, the U.K. government have an antibody test lined up for imminent home use rollout with the option to register interest.
Given the fact they set up a government backed consortium to provide an antibody test for home use which has been in development for over 6 months and is gold standard with 99.40% accurate. As well as all the other signals with updated government guidance, antibodies promoting immunity, Ulster study stating imminent rollout in interviews, significant demand outlined in correspondence by CIGA... I’m probably only scratching the surface.
I expect many will need it written in an RNS though, but obviously that’ll come with a substantial price tag. Hence why those who are well informed know that we’ll be looking back at sub £1 and realise it was absolute bargain territory.
https://www.gov.uk/government/publications/coronavirus-covid-19-antibody-tests/coronavirus-covid-19-antibody-tests
“At-home antibody test kits
This is the start of the UK’s at-home antibody test kit programme.
You can get a free at-home antibody test if all of these apply:
you live in England or Wales
you’re 18 or over
you work in adult social care (England) or domiciliary care (Wales) and get paid”
1) MHRA for home use: updates can take a few weeks if not up to 3 months from the time of submission so we may have a bit of a wait. Until then, we still have approval for healthcare professional (HCP) use we can maximise on. The products scope of use is versatile globally even in countries where labs are scarce.
If we don’t get MHRA approval for home use it all depends when we find out. Firstly if we find out the decision sooner, we can still cater to HCP and plans still go ahead. If we find out later, the product will still be sold for HCP use. In either case, with or without MHRA approval the test will be sold to the wider market. The demand is there. In the UK HCP could use the test for patients and results can be scanned to the NHS app. Bypasses the need for home use.
2) Boris brother in covid test company: not much you can do. There will always be conflicts of interest and the government will always try to make money by undercutting/picking the less desirable product as long as you are chums with the MP’s or married to one like Dido. However the market is big enough for everyone. Just because the UKRTC had a government hand in it, the government don’t have to choose it. Better to pick a test/company that lines the pocket of others. If we don’t get government orders, great! Greater profit margins and no need to deal with the beaurocracy / house of cards like manner of the government. We have a great product which is one of the best globally. Better to have a product that has great results verses one that just built on hype and underperforms. It will sell itself.
3) Competition: makes things interesting. The market is big enough. I wish we had the Mologic antigen saliva test ready to go. Walbrook informed me that it’s in development but still developed enough for the Heathrow trial. It’s due to be ready end of the ready with MTA to ODX thereafter and CE approval. Once again this has lots of scope to HCP globally. Its interesting as some people flying abroad need to pay for a covid test 72 hours prior to travel. This is often done privately, costs around £100ish and funnily enough some of the companies use the NHS labs to test this. Here’s me thinking that there was a lack of lab capacity. Of course there would be if the NHS labs are being used for other demands. Imagine the dent to their profits when this hits the market.
The second week of October will be interesting MHRA approval or not, government orders or not.